Lupin Share Price
Mid Cap | Pharmaceuticals and health care | NSE: LUPIN | BSE: 500257
₹1,906.15 
-71.45 (-3.61 %)
Last Updated: 21 Feb 2025 04:01 PM
BEARISH
Overview
Open (₹) 1,994.95
High (₹) 1,994.95
Low (₹) 1,902.60
Prev. Close (₹) 1,977.60
Volume 12,757
VWAP (₹) 1,930.71
ROCE (%) 17.64
Industry P/E 43.99
TTM P/E 30.33
P/B Ratio 6.04
Market Cap (₹) Cr.86,975.61
Dividend Yield (%)0.42
EPS (₹) 41.87
ROE13.27%
Sales Growth (%) 20.25
Profit Growth (%)332.35
Day Range
1,994.951,994.95
52 Week Range
1,493.752,403.45
Historical Returns
Returns (6M)
-9.95 %
Returns (1Y)
18.23 %
Returns (3Y)
151.72 %
Returns (5Y)
183.13 %
Returns (6M)
-9.95 %
Returns (1Y)
18.23 %
Returns (3Y)
151.72 %
Returns (5Y)
183.13 %
SWOT Analysis
- Effectively using its capital to generate profits - ROCE improved in the last year
- Company with (344.95%) TTM EPS Growth
- Company with Low Debt
- Book value per share improving over the last 2 years
- Efficient in managing Assets to generate Profits - ROA improved since last year
- Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
- Company with 344.95% positive TTM EPS growth
- Increasing Annual Revenue for Past 2 Years
- Growth in Net Profit Margin (QoQ)
- Growth in Annual Net Profit with increasing Profit Margin (YoY)
- Bullish MACD crossover (12,6,9) indicates potential upward price movement.
Technicals
Technical Rating
BEARISHRSI 47.15
MFI 47.40
ATR 89.51
Commodity Channel Index -144.11
ROC125 -8.96
ROC21 -10.67
Williams %R -97.90
Resistance & Support
| Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
|---|---|---|---|---|---|---|---|
| Current | 1,966.54 | 2,026.92 | 2,058.89 | 1,934.57 | 1,874.19 | 1,842.22 | 1,781.84 |
| Week Ago | 2,060.36 | 2,152.18 | 2,215.71 | 1,996.83 | 1,905.01 | 1,841.48 | 1,749.66 |
| Month Ago | 2,140.74 | 2,178.07 | 2,199.84 | 2,118.97 | 2,081.64 | 2,059.87 | 2,022.54 |
EMA & SMA
1906.15
Current Price
Bullish Moving Averages
0
Bearish Moving Averages
20
5 Day 1995.13
9 Day 2014.60
10 Day 2045.99
12 Day 2076.58
14 Day 2068.50
20 Day 2056.18
26 Day 2078.46
50 Day 2134.92
100 Day 2136.00
200 Day 1999.98
Deals & Announcements
Bulk and Block Deals
| Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
|---|---|---|---|---|---|---|
| BNP PARIBAS ARBITRAGE | block | Sell | 25 Jan, 2024 | ₹1,449.20 | 7,47,956 | BSE |
| SOCIETE GENERALE | block | Buy | 25 Jan, 2024 | ₹1,449.20 | 7,47,956 | BSE |
| ISHARES CORE EMERGING MARKETS MAURITIUS CO | block | Sell | 25 Oct, 2022 | ₹680.75 | 2,13,033 | BSE |
| ISHARES CORE MSCI EMERGING MARKETS ETF | block | Buy | 25 Oct, 2022 | ₹680.75 | 2,13,033 | BSE |
| ISHARES CORE EMERGING MARKETS MAURITIUS CO | block | Sell | 17 Oct, 2022 | ₹690.65 | 3,34,753 | BSE |
| ISHARES CORE MSCI EMERGING MARKETS ETF | block | Buy | 17 Oct, 2022 | ₹690.65 | 3,34,753 | BSE |
| ISHARES CORE EMERGING MARKETS MAURITIUS CO | block | Sell | 11 Oct, 2022 | ₹707.20 | 2,45,503 | BSE |
| ISHARES CORE MSCI EMERGING MARKETS ETF | block | Buy | 11 Oct, 2022 | ₹707.20 | 2,45,503 | BSE |
| ISHARES INDIA INDEX MAURITIUS COMPANY | block | Sell | 18 Jul, 2022 | ₹640.85 | 2,42,963 | BSE |
| ISHARES MSCI INDIA ETF | block | Buy | 18 Jul, 2022 | ₹640.85 | 2,42,963 | BSE |
Insider Trading
| Date | Name | Action | Avg. Price | Quantity | Deal Value |
|---|---|---|---|---|---|
| 09 Sept, 2021 | Dr. Kamal K Sharma | Disposal | ₹985.00 | 15,000 | BSE |
| 06 Sept, 2021 | Neel Deshbandhu Gupta | Acquisition | ₹ | 2,650 | BSE |
| 06 Sept, 2021 | Veda Nilesh Gupta | Acquisition | ₹ | 2,650 | BSE |
| 06 Sept, 2021 | Nilesh D. Gupta | Disposal | ₹ | 5,300 | BSE |
| 27 Aug, 2021 | Nilesh D. Gupta | Acquisition | ₹943.58 | 5,300 | BSE |
| 18 Aug, 2021 | Sunil Makharia | Disposal | ₹974.00 | 20,000 | BSE |
| 16 Aug, 2021 | Ramesh Swaminathan | Disposal | ₹978.00 | 10,000 | BSE |
| 10 Jul, 2021 | Veda Nilesh Gupta | Acquisition | ₹ | 2,140 | BSE |
| 10 Jul, 2021 | Nilesh D. Gupta | Disposal | ₹ | 2,140 | BSE |
| 30 Jun, 2021 | Mr. Sunil Makharia | Disposal | ₹1,161.00 | 2,000 | BSE |
Corporate Actions
| Announcement Date | Subject | Ex - Date | Record Date |
|---|---|---|---|
| 06 May, 2024 | Rs.8.0000 per share(400%)Final Dividend | 16 Jul, 2024 | 16 Jul, 2024 |
| 10 May, 2023 | Rs.4.0000 per share (200%)Final Dividend | 14 Jul, 2023 | 14 Jul, 2023 |
| 18 May, 2022 | Rs.4.0000 per share(200%)Final Dividend | 14 Jul, 2022 | 15 Jul, 2022 |
Announcements
| Date | Source | Detail |
|---|---|---|
| 21 Feb, 2025 | BSE India | Lupin Receives EIR from U. S. FDA for its Somerset Manufacturing Facility. |
| 19 Feb, 2025 | BSE India | Transcript of Q3 FY2025 Earnings Conference Call. |
| 19 Feb, 2025 | NSE India | Lupin Limited has informed the Exchange about Transcript of Q3 FY2025 Earnings Conference Call. |
| 19 Feb, 2025 | BSE India | Intimation about participating in the Analyst/Investors Meet. |
| 19 Feb, 2025 | NSE India | Lupin Limited has informed the Exchange about Schedule of meet. |
| 19 Feb, 2025 | NSE India | Lupin Limited has informed the Exchange about Copy of Newspaper Publication w.r.t. dispatch of Postal Ballot Notice. |
| 19 Feb, 2025 | NSE India | Lupin Limited has informed the Exchange regarding a press release dated February 19, 2025, titled ""Lupin Receives A- Leadership Rating from CDP in Two Categories Climate Change and Water Security"". |
| 19 Feb, 2025 | BSE India | Lupin Receives \A-\ Leadership Rating from CDP in Two Categories - Climate Change and Water Security. |
| 18 Feb, 2025 | NSE India | Lupin Limited has informed the Exchange about Notice of Shareholders Meeting for Postal Ballot |
| 18 Feb, 2025 | BSE India | Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Postal Ballot Notice. |
Board Meetings
| Purpose | Details | Meeting Date | Broadcast Date |
|---|---|---|---|
| Quarterly Results & Others | To consider other business matters. | 29 Jan, 2025 | 11 Feb, 2025 |
| Quarterly Results | -- | 23 Oct, 2024 | 07 Nov, 2024 |
| Quarterly Results | -- | 24 Jul, 2024 | 06 Aug, 2024 |
| Audited Results & Final Dividend | -- | 23 Apr, 2024 | 06 May, 2024 |
| Quarterly Results | -- | 24 Jan, 2024 | 07 Feb, 2024 |
| Quarterly Results | -- | 26 Oct, 2023 | 08 Nov, 2023 |
| Quarterly Results | -- | 24 Jul, 2023 | 03 Aug, 2023 |
| Audited Results & Final Dividend | -- | 26 Apr, 2023 | 09 May, 2023 |
| Quarterly Results | -- | 26 Jan, 2023 | 09 Feb, 2023 |
| Quarterly Results | -- | 09 Nov, 2022 | 09 Nov, 2022 |
Share Holding Pattern
| Owner Name | Dec, 2024 | Sept, 2024 | Jun, 2024 | Mar, 2024 | Dec, 2023 |
|---|
About Lupin
Lupin is a Public Limited Listed company incorporated on 01/03/1983 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24100MH1983PLC029442 and registration number is 029442. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 14666.50 Cr. and Equity Capital is Rs. 91.14 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Lupin Group
Founded
1983
Managing Director
Mr. Nilesh D Gupta
NSE Symbol
LUPIN
Lupin Management
| Name | Designation |
|---|---|
| Mrs. Manju D Gupta | Chairman |
| Mr. Nilesh D Gupta | Managing Director |
| Ms. Vinita Gupta | Director & CEO |
| Mr. Ramesh Swaminathan | Executive Director & Global CFO |
| Mr. Mark D McDade | Independent Director |
| Dr. Punita Kumar-Sinha | Independent Director |
| Mr. Jean-Luc Belingard | Independent Director |
| Mr. Jeffrey Kindler | Independent Director |
| Mr. Alfonso Zulueta | Independent Director |
Peer Comparison
| Stocks | Market Cap | Market Price | 52 Week Low-High |
|---|---|---|---|
| SunPhrmInds | ₹4,46,576.22 | ₹1,643.75  ₹1,669.30(-1.53%) | ₹1,249.800 - ₹1,960.200 |
| Divis Labora | ₹1,56,123.40 | ₹5,757.05 ₹5,978.30(-3.70%) | ₹3,350.050 - ₹6,448.750 |
| Cipla | ₹1,21,675.13 | ₹1,475.75 ₹1,479.70(-0.27%) | ₹1,240.700 - ₹1,702.000 |
| ManKind Phar | ₹1,18,478.90 | ₹2,327.75 ₹2,348.45(-0.88%) | ₹1,910.100 - ₹3,050.000 |
| DrReddysLab | ₹1,15,939.04 | ₹1,151.80 ₹1,170.95(-1.64%) | ₹1,104.690 - ₹1,420.200 |
FAQs on Lupin
What is the share price of Lupin?
The share price of Lupin on 21 Feb, 2025 is ₹ 1,906.15.
What is 52W high and 52W low share price of Lupin?
The highest and lowest 52W share prices of Lupin are ₹ 2312.000 and ₹ 1289.150
What is the market cap of Lupin?
The market capitalization of Lupin as of 21 Feb, 2025 is ₹ 86,975.61 Crores
What is the P/E ratio of Lupin?
The current P/E ratio of Lupin as of 21 Feb, 2025 is 43.99
What is the PB ratio of Lupin?
The PB ratio of Lupin as of 21 Feb, 2025 is 6.04
Top Gainers
948IHFL26I
IBHFL NCD186
₹845.00
₹705.00 (0.20%)
GREAVESCOT
Greaves
₹281.85
₹234.90 (0.20%)
ASHSI
Ashirwd Stl
₹45.66
₹38.05 (0.20%)
CAPRO
Caprola.Chem
₹62.40
₹52.00 (0.20%)
Top Losers
DHANBANK
Dhanalak.Bnk
₹32.19
₹35.97 (-0.11%)
08MPD
08MPD
₹8.66
₹9.62 (-0.10%)
BALTE
BalurghtTran
₹27.13
₹31.24 (-0.13%)
DARSHANORNA
Darshan Orna
₹4.57
₹5.07 (-0.10%)
Market Indices
Sensex
₹78,699.07
₹78,472.48 (0.00%)